CD44+CD24− cells have been proposed to represent cancer stem cells in breast cancer [41], as well as in head and neck squamous cell carcinoma (the latter includes an ALDH1+CD44+CD24− stem cell subset) [42]. This evidence concerns the gene CD24 and breast carcinoma.